Filing Flows › Silence Therapeutics (SLN) › How it makes money
How Silence Therapeutics (SLN) makes money
Silence Therapeutics (SLN) made $422K of revenue in the first quarter 2026 (Q1 2026), +197% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2026 | % of revenue |
|---|---|---|
| Revenue | $422K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2026 | $422K | +197% |
| Q4 2025 | $34K | -100% |
| Q3 2025 | $159K | -89% |
| Q2 2025 | $224K | -70% |
| Q1 2025 | $142K | -99% |
| Q4 2024 | $25.3M | — |
From Silence Therapeutics' 10-Q filed May 7, 2026 (on EDGAR).
Questions
How does Silence Therapeutics make money?
Silence Therapeutics (SLN) made $422K of revenue in the first quarter 2026 (Q1 2026), +197% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.